Profile | GDS5420 / 239929_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 176.98 | 50 |
GSM1296119 | B_lesional_pre-dose | 369.17 | 63 |
GSM1296076 | C_lesional_pre-dose | 37.52 | 26 |
GSM1296092 | D_lesional_pre-dose | 1296.2 | 82 |
GSM1296103 | E_lesional_pre-dose | 57.73 | 34 |
GSM1296078 | F_lesional_pre-dose | 38.47 | 27 |
GSM1296107 | G_lesional_pre-dose | 546.04 | 69 |
GSM1296109 | H_lesional_pre-dose | 35.72 | 24 |
GSM1296080 | I_lesional_pre-dose | 350.49 | 62 |
GSM1296090 | J_lesional_pre-dose | 2549.09 | 91 |
GSM1296074 | K_lesional_pre-dose | 419 | 66 |
GSM1296111 | L_lesional_pre-dose | 22.24 | 16 |
GSM1296099 | M_lesional_pre-dose | 368.84 | 62 |
GSM1296086 | O_lesional_pre-dose | 20.45 | 19 |
GSM1296117 | P_lesional_pre-dose | 453.28 | 66 |
GSM1296113 | Q_lesional_pre-dose | 652.54 | 72 |
GSM1296096 | R_lesional_pre-dose | 115.21 | 44 |
GSM1296105 | S_lesional_pre-dose | 40.51 | 27 |
GSM1296098 | T_lesional_pre-dose | 28.94 | 19 |
GSM1296101 | U_lesional_pre-dose | 298.26 | 58 |
GSM1296121 | V_lesional_pre-dose | 1664.01 | 87 |
GSM1296088 | W_lesional_pre-dose | 54.39 | 33 |
GSM1296082 | X_lesional_pre-dose | 4636.37 | 96 |
GSM1296115 | Y_lesional_pre-dose | 21.39 | 17 |
GSM1296084 | Z_lesional_pre-dose | 2893.79 | 93 |
GSM1296072 | B_lesional_day8 | 1595.55 | 86 |
GSM1296069 | L_lesional_day8 | 53.13 | 28 |
GSM1296071 | P_lesional_day8 | 968.48 | 79 |
GSM1296070 | Y_lesional_day8 | 47.94 | 27 |
GSM1296073 | V_lesional_day8 | 1946.8 | 88 |
GSM1296034 | A_lesional_day15 | 936.75 | 78 |
GSM1296041 | G_lesional_day15 | 126.09 | 44 |
GSM1296035 | R_lesional_day15 | 250.3 | 56 |
GSM1296038 | U_lesional_day15 | 602.24 | 71 |
GSM1296047 | B_lesional_day15 | 954.41 | 79 |
GSM1296039 | E_lesional_day15 | 67.29 | 36 |
GSM1296042 | H_lesional_day15 | 20.41 | 15 |
GSM1296043 | L_lesional_day15 | 15.7 | 12 |
GSM1296037 | M_lesional_day15 | 3983.14 | 96 |
GSM1296046 | P_lesional_day15 | 35.85 | 22 |
GSM1296044 | Q_lesional_day15 | 1511.8 | 86 |
GSM1296045 | Y_lesional_day15 | 41.59 | 24 |
GSM1296025 | C_lesional_day15 | 981.91 | 79 |
GSM1296033 | D_lesional_day15 | 3407.39 | 95 |
GSM1296027 | I_lesional_day15 | 1506.05 | 85 |
GSM1296032 | J_lesional_day15 | 4371.82 | 97 |
GSM1296024 | K_lesional_day15 | 778.14 | 75 |
GSM1296031 | W_lesional_day15 | 1374.16 | 84 |
GSM1296028 | X_lesional_day15 | 7528.65 | 99 |
GSM1296029 | Z_lesional_day15 | 1020.02 | 79 |
GSM1296026 | F_lesional_day15 | 112.19 | 44 |
GSM1296030 | O_lesional_day15 | 180.95 | 53 |
GSM1296040 | S_lesional_day15 | 176.69 | 50 |
GSM1296036 | T_lesional_day15 | 890.04 | 77 |
GSM1296048 | V_lesional_day15 | 1371.88 | 84 |
GSM1296059 | A_lesional_day43 | 186.61 | 52 |
GSM1296066 | G_lesional_day43 | 389.57 | 63 |
GSM1296060 | R_lesional_day43 | 443.22 | 65 |
GSM1296063 | U_lesional_day43 | 391.61 | 64 |
GSM1296064 | E_lesional_day43 | 3237.55 | 93 |
GSM1296067 | H_lesional_day43 | 61.64 | 31 |
GSM1296062 | M_lesional_day43 | 1828.53 | 88 |
GSM1296068 | Q_lesional_day43 | 891.01 | 78 |
GSM1296050 | C_lesional_day43 | 149.7 | 48 |
GSM1296057 | D_lesional_day43 | 1563.57 | 86 |
GSM1296052 | I_lesional_day43 | 60.88 | 36 |
GSM1296054 | J_lesional_day43 | 3161.35 | 95 |
GSM1296049 | K_lesional_day43 | 2694.44 | 92 |
GSM1296055 | W_lesional_day43 | 1191.4 | 82 |
GSM1296053 | X_lesional_day43 | 5842.83 | 98 |
GSM1296058 | Z_lesional_day43 | 3239.92 | 95 |
GSM1296051 | F_lesional_day43 | 163.57 | 50 |
GSM1296056 | O_lesional_day43 | 31.5 | 26 |
GSM1296065 | S_lesional_day43 | 821.04 | 76 |
GSM1296061 | T_lesional_day43 | 133.03 | 45 |
GSM1296095 | A_non-lesional_pre-dose | 55.86 | 33 |
GSM1296120 | B_non-lesional_pre-dose | 3716.98 | 96 |
GSM1296077 | C_non-lesional_pre-dose | 1080.83 | 80 |
GSM1296093 | D_non-lesional_pre-dose | 6304.01 | 99 |
GSM1296104 | E_non-lesional_pre-dose | 9538.13 | 98 |
GSM1296079 | F_non-lesional_pre-dose | 181.17 | 51 |
GSM1296108 | G_non-lesional_pre-dose | 666.78 | 73 |
GSM1296110 | H_non-lesional_pre-dose | 582.72 | 70 |
GSM1296081 | I_non-lesional_pre-dose | 56.24 | 35 |
GSM1296091 | J_non-lesional_pre-dose | 3701.36 | 96 |
GSM1296075 | K_non-lesional_pre-dose | 3079.62 | 93 |
GSM1296112 | L_non-lesional_pre-dose | 25.36 | 16 |
GSM1296100 | M_non-lesional_pre-dose | 2876.54 | 93 |
GSM1296087 | O_non-lesional_pre-dose | 387.8 | 64 |
GSM1296118 | P_non-lesional_pre-dose | 2770.76 | 94 |
GSM1296114 | Q_non-lesional_pre-dose | 1385.1 | 85 |
GSM1296097 | R_non-lesional_pre-dose | 1223.49 | 82 |
GSM1296106 | S_non-lesional_pre-dose | 2374.79 | 92 |
GSM1296102 | U_non-lesional_pre-dose | 1474.65 | 85 |
GSM1296122 | V_non-lesional_pre-dose | 7160.81 | 99 |
GSM1296089 | W_non-lesional_pre-dose | 479.99 | 66 |
GSM1296083 | X_non-lesional_pre-dose | 1299.93 | 83 |
GSM1296116 | Y_non-lesional_pre-dose | 882.34 | 77 |
GSM1296085 | Z_non-lesional_pre-dose | 5955.77 | 98 |